Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.76B
Close$
$4.32
88.1% downside
Current Fair Value
88.1% downsideOvervalued by 88.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.76 Billion |
|---|---|
| Enterprise Value | $2.72 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.66 |
| Beta | 0.92 |
| Outstanding Shares | 71,476,595 |
Return
| Return on Equity | -73.84% |
|---|---|
| Return on Assets | -59.34% |
| Return on Invested Capital | -64.03% |
Valuation & Multiples
| P/E Ratio | -6.95 |
|---|---|
| PEG | -5.18 |
| Price to Sales | - |
| Price to Book Ratio | 6.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.38 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-1.33
Average shareholder expectationRevenue Estimate
$426,033
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.60
Average shareholder expectationRevenue Estimate
$1.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 8.34% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.45%▼ 112.00% |
|---|---|
| Total Invested | $13.88M▼ 99.52% |
| Investors Holding | 15▼ 223.00% |
ESG Score
No data
About Vera Therapeutics Inc
19 employees